| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
42,976 | 14,323 | 7,578 | ||||
Operating expenses: | ||||||
Research and development | ||||||
67,193 | 45,193 | 28,792 | ||||
General and administrative | ||||||
27,307 | 12,932 | 3,546 | ||||
Total operating expenses | ||||||
94,500 | 58,125 | 32,339 | ||||
Income (loss) from operations | ||||||
-51,524 | -43,802 | -24,760 | ||||
Other income (expenses) | ||||||
Other income | ||||||
1,435 | 102 | 554 | ||||
Change in fair value of preferred unit warrant | ||||||
0 | 193 | -5 | ||||
Interest income | ||||||
4,557 | 2,470 | 201 | ||||
Interest expense | ||||||
85 | 57 | 50 | ||||
Total other income | ||||||
5,907 | 2,321 | 711 | ||||
Loss from equity method investment | ||||||
-24,675 | 0 | - | ||||
Net loss | ||||||
-70,292 | -41,480 | -24,049 | ||||
Change in redemption value of redeemable preferred units | ||||||
0 | 198,366 | 4,570 | ||||
Net loss attributable to common shares | ||||||
-70,292 | -239,847 | -28,619 | ||||
Net loss per common share, basic and diluted | ||||||
-2.13 | -25.45 | -15.08 | ||||
Weighted average common shares outstanding, basic and diluted | ||||||
32,927 | 9,422 | 1,897 | ||||